Procter & Gamble Beats Q1 Estimates With 4% Sales Rise but Flags $1.4B Commodity Headwind

Procter & Gamble posted stronger-than-expected first-quarter fiscal 2027 results on October 22, with net sales rising 4% year over year to $23.28 billion against a Wall Street estimate of $22.82 billion. Core earnings per share of $2.00 beat the $1.89 consensus by $0.11, while organic sales grew 4%, more than double the 1.96% analysts had forecast. The stock gained following the report.

All five business segments beat organic sales estimates. Beauty led with 5.4% organic growth against a 3.58% estimate, Grooming surged 4.5% versus a 0.7% forecast, Fabric and Home Care rose 4.8% versus 2.35%, Baby, Feminine and Family Care grew 3.0% against 0.99%, and Health Care added 2.7% in line with its 2.51% estimate. Operating cash flow reached $5.8 billion, with adjusted free cash flow productivity at 93%. P&G returned $2.6 billion in dividends and $1.3 billion in share repurchases during the quarter.

Margin pressure emerged as a key concern. Core gross margin came in at roughly 49.8% to 50.0%, down about 150 basis points year over year, and core operating margin fell 80 basis points to 25.9%. P&G now expects commodity costs to reduce fiscal 2027 after-tax profit by approximately $1.4 billion, up from its prior estimate of $1.0 billion, reflecting higher fuel and raw material costs.

For full-year fiscal 2027, P&G held its core EPS guidance range of $6.89 to $7.11 and organic sales growth of 1% to 3%, but raised its all-in net sales growth outlook to 2% to 4%, citing the Thorne acquisition, which became effective October 1, 2026. CEO Shailesh Jejurikar said the results reflect "sharpened execution" of the company's integrated strategy and that the strong start keeps P&G on track despite continuing geopolitical and economic challenges.